European multicentre evaluation of the analytical performance of the Abbott AxSYM abused drugs assays

European Journal of Clinical Chemistry and Clinical Biochemistry

Volumn 35, Issue 2, 1997, Pages 133-140

  Von Meyer, Ludwig ^a,b,c,d,e   Hänseler, Edgar ^a   Lardet, Gisèle ^a   Schaler, André ^a   Sieghart, Werner ^a  

^a Institut fur Rechtsmedizin   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID; COCAINE; OPIATE;

ACCURACY; ANALYTIC METHOD; ARTICLE; AUTOANALYZER; CALIBRATION; CLINICAL LABORATORY; COMPUTER PROGRAM; CONTAMINATION; CONTROLLED STUDY; DRUG ABUSE; DRUG SCREENING; DRUG URINE LEVEL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; STANDARD;

CALIBRATION; EUROPE; EVALUATION STUDIES; HUMANS; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; SOFTWARE; STREET DRUGS;

EID: 0030894274     PISSN: 09394974     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Haeckel R, Busch EW, Jennings RD, Truchaud A. ECCLS Documents 3, No. 2, Berlin: Beuth Verlag, 1983.
2. Smith J, Osikowicz G, Tayi R, Walker B, Marlin R, Vaught J, et al. Abbott AxSYM random and continuous access immunoassay system for improved workflow in the clinical laboratory. Clin Chem 1993; 39:2063-9.
3. Jolley ME. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. J Anal Toxicol 1981; 5:236-40.
4. Armbruster DA, Schwarzkopf RH, Hubster EC, Liserio MK. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening. Clin Chem 1993; 39:2137-46.
5. Jortani SA, Poklis A. Evaluation of the Syva ETS Plus urine drug and serum ethanol analyzer. J Anal Toxicol 1993; 17:31-3.
6. Arabshahi L, Goetze A, Hui R, Stoecker P, Subuhi H, SundoroWu R, et al. Abuscreen ONEINE immunoassay for the detection of benozdiazepines in urine on the Cobas Mira [abstract]. Clin Chem 1993; 37:995.
7. Miceli JN, Vroon DH, Harris CJ. Use of the REMEDI drug profiling system [abstract]. Ther Drug Monit 1993; 15:164.
8. Zürcher M. Departement Zentrallaboratorium des Kantonsspitals Basel, Standardarbeitsanweisung SOP-CHE.M.608.01, 20. 10. 1994, I ff.
9. Adaptation of Applications of AASP No10, SEP-4394/885, Varian AG, Basel on the Hitachi Merck.
10. National Institute on Drug Abuse and Department of Health and Human Services. The NIDA Guidelines 1988; Subpart B, Section 2.4(c,h). Federal Register, Vol. 59, No. 100, 9.
11. Scholar A, Böhmer M, Lemp K, Muser J. Evaluation der Roche Abuscreen "OnLine" Drogenbestimmungsmethoden im Urin auf dem COBAS MIRA S Plus [poster]. Annual Meeting of the Swiss Society of Clinical Chemistry, Interlaken, 1994.